Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blinded, Randomized, Parallel Group, Multi-Center, Multi-National Comparative Study of the Safety and Efficacy of Cethromycin 300 mg QD to Clarithromycin 250 mg BID for the Treatment of Community-Acquired Pneumonia in Adults

NCT00336544 is registered in ClinicalTrials.gov with Advanced Life Sciences, Inc. as lead sponsor.

NCT NCT00336544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00336544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blinded, Randomized, Parallel Group, Multi-Center, Multi-National Comparative Study of the Safety and Efficacy of Cethromycin 300 mg QD to Clarithromycin 250 mg BID for the Treatment of Community-Acquired Pneumonia in Adults
Lead sponsor
Advanced Life Sciences, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2006
Completion date
May 31, 2007
Enrollment
522 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia